#BEGIN_DRUGCARD DB01880

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
331-39-5

# ChEBI_ID:
17395

# Chemical_Formula:
C9H8O4

# Chemical_IUPAC_Name:
(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Antioxidants

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
1.15

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3,4-Dihydroxycinnamic Acid

# HET_ID:
DHC

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2+

# InChI_Key:
InChIKey=QAIPRVGONGVQAS-DUXPYHPUSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C01481

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1880

# Mechanism_Of_Action:
Not Available

# Melting_Point:
225 dec °C

# Molecular_Weight_Avg:
180.1574

# Molecular_Weight_Mono:
180.042258744

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KOU

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.67

# Predicted_LogS:
-2

# Predicted_Water_Solubility:
1.61e+00 g/l

# Primary_Accession_No:
DB01880

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
689043

# PubChem_Substance_ID:
46504491

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01188

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)\C=C\C1=CC(O)=C(O)C=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:34 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
4.62 (at 25 °C)

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U17017

# Drug_Target_1_GenBank_ID_Protein:
602429

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
pyp

# Drug_Target_1_Gene_Sequence:
>378 bp
ATGGAACACGTAGCCTTCGGTAGCGAGGACATCGAGAACACCCTCGCCAAGATGGACGAC
GGCCAGCTCGACGGCCTGGCCTTCGGCGCCATCCAGCTCGACGGCGACGGCAACATCCTT
CAGTACAACGCCGCGGAGGGCGACATCACCGGCCGCGACCCGAAGCAGGTCATCGGCAAG
AACTTCTTCAAGGACGTGGCCCCGTGCACTGACAGCCCGGAGTTCTACGGCAAGTTCAAG
GAAGGGGTGGCCTCGGGCAACCTGAACACGATGTTCGAGTACACCTTCGATTACCAAATG
ACGCCCACGAAGGTGAAGGTGCACATGAAGAAGGCCCTCTCCGGCGACAGCTACTGGGTC
TTCGTCAAGCGCGTCTAG

# Drug_Target_1_General_Function:
Involved in signal transducer activity

# Drug_Target_1_General_References:
10739248	van Aalten DM, Crielaard W, Hellingwerf KJ, Joshua-Tor L: Conformational substates in different crystal forms of the photoactive yellow protein--correlation with theoretical and experimental flexibility. Protein Sci. 2000 Jan;9(1):64-72.
2771940	McRee DE, Tainer JA, Meyer TE, Van Beeumen J, Cusanovich MA, Getzoff ED: Crystallographic structure of a photoreceptor protein at 2.4 A resolution. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6533-7.
7981196	Baca M, Borgstahl GE, Boissinot M, Burke PM, Williams DR, Slater KA, Getzoff ED: Complete chemical structure of photoactive yellow protein: novel thioester-linked 4-hydroxycinnamyl chromophore and photocycle chemistry. Biochemistry. 1994 Dec 6;33(48):14369-77.
8358295	Van Beeumen JJ, Devreese BV, Van Bun SM, Hoff WD, Hellingwerf KJ, Meyer TE, McRee DE, Cusanovich MA: Primary structure of a photoactive yellow protein from the phototrophic bacterium Ectothiorhodospira halophila, with evidence for the mass and the binding site of the chromophore. Protein Sci. 1993 Jul;2(7):1114-25.
8573584	Hoff WD, Devreese B, Fokkens R, Nugteren-Roodzant IM, Van Beeumen J, Nibbering N, Hellingwerf KJ: Chemical reactivity and spectroscopy of the thiol ester-linked p-coumaric acid chromophore in the photoactive yellow protein from Ectothiorhodospira halophila. Biochemistry. 1996 Jan 30;35(4):1274-81.
8670821	Kort R, Hoff WD, Van West M, Kroon AR, Hoffer SM, Vlieg KH, Crielaand W, Van Beeumen JJ, Hellingwerf KJ: The xanthopsins: a new family of eubacterial blue-light photoreceptors. EMBO J. 1996 Jul 1;15(13):3209-18.
9045611	Genick UK, Borgstahl GE, Ng K, Ren Z, Pradervand C, Burke PM, Srajer V, Teng TY, Schildkamp W, McRee DE, Moffat K, Getzoff ED: Structure of a protein photocycle intermediate by millisecond time-resolved crystallography. Science. 1997 Mar 7;275(5305):1471-5.
9515969	Genick UK, Soltis SM, Kuhn P, Canestrelli IL, Getzoff ED: Structure at 0.85 A resolution of an early protein photocycle intermediate. Nature. 1998 Mar 12;392(6672):206-9.
9665170	Rubinstenn G, Vuister GW, Mulder FA, Dux PE, Boelens R, Hellingwerf KJ, Kaptein R: Structural and dynamic changes of photoactive yellow protein during its photocycle in solution. Nat Struct Biol. 1998 Jul;5(7):568-70.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2369

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
13874

# Drug_Target_1_Name:
Photoactive yellow protein

# Drug_Target_1_Number_of_Residues:
125

# Drug_Target_1_PDB_ID:
1OTB

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00989	PAS

# Drug_Target_1_Protein_Sequence:
>Photoactive yellow protein
MEHVAFGSEDIENTLAKMDDGQLDGLAFGAIQLDGDGNILQYNAAEGDITGRDPKQVIGK
NFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYTFDYQMTPTKVKVHMKKALSGDSYWV
FVKRV

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Photoactive blue-light protein. Probably functions as a photoreceptor for a negative phototaxis response

# Drug_Target_1_SwissProt_ID:
P16113

# Drug_Target_1_SwissProt_Name:
PYP_HALHA

# Drug_Target_1_Synonyms:
PYP

# Drug_Target_1_Theoretical_pI:
4.56

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
CP000144

# Drug_Target_2_GenBank_ID_Protein:
77389407

# Drug_Target_2_GeneCard_ID:
hutH

# Drug_Target_2_Gene_Name:
hutH

# Drug_Target_2_Gene_Sequence:
>1572 bp
ATGCGAGGGCGTGAGGCAAGCAGGGAGACTGGCGCCAGCCAATCAGATCCCGACGTGCCC
GCCGTCGCCTACGTCCGGATGTCGACCGATCACCAGAAGTATTCGACAGAGAACCAGTTG
GACGTCATCCGCAGCTATGCGGCCGCCCGCGGCCTGCAGATTCTGCGCGTTTTCGAGGAC
TCTGGGCGCTCAGGCCTCCGTCTCGATGGTCGCGAGGCGCTGCAGAACCTGATGGGCGAA
GTTCAATCAGGCCGGGCCGACTTCAAGGCCATCCTCGTCTACGACGTCAGCCGTTGGGGC
CGGTTTCAGGATGCCGACGAAGGCGCCTACCACGAGCACGTATGTTCCCGTGCCGGCATC
CGGGTCCACTACTGCGGCGAGCAGTTCGAGAACGACGGCAGCATCGGCTCGAACCTCCTG
AAAACCGTCAAGCGCGTGATGGCGGGCGAATACAGCCGCGAGCTGTCGGTGAAGGTCTTC
GCCGGGCAATGCCGCCTCGTGGAGCTTGGCTATCGCCAGGGCGGCGCCGCCGGATACGGG
CTGCGGCGGGTTCTGATCGACGAGCACGGCAGCCCGAAGGGCGAGCTGTCCCGTGGCGAG
CAGAAGAGCCTGCAGACCGACCGAGTGATCCTGGTGCCCGGCCCCGAGGAAGAGCAGCGG
GTCGTCCAGCGCATGTACGCGATGTTCGTCGACGAGGGGCGGCCGGAGCGCGAGATCGCG
AAGATTCTGAATGCCGATGGACACCGGACCGATCTTGACCGTCCATGGACGCGTGCGACC
GTCCATCAGGTGCTGACCAGTGAAAAATACATCGGGAACAATGTCTTCGCGAAGGTGTCG
TTCAAGCTGAAGCAGCGCCGCGTGGTGAACCCGCGGGAGATGTGGATCCGCGCCGAGGGT
GCCTATCCCGCCATCGTCGATCAGGCGCTGTTCCTGCGTGCGCGGGAGATCGTGGATGCG
CGAAGCCGGCATTTCTCGGACGAGCAACTGCTCGACGCGCTGCGCGCGATCCTCCGGCGA
CAAGGCATGCTGTCGGGCCTGATCATCGACGAGGAGGAAAACCTGCCGTCCTCCAGCGCC
TATCGCAGCCGCTTCGGCAGCCTCCTGCGCGCCTACCGCTTGATCGGATACGAGCCGGAT
CGCGACTACAGCTATATCGAGGCAAACCGGGCTCTGCGGCAGGCCCATCCGCAGGTCGTG
GCCGAAATCATAGCTGGCGTCACCCGGCATGGCGGGTCGGCCGTGCAGGACCCTGACACC
GATCTGGTTCGCGTCAACGACGAGTTCACGGTGTCCATCGTGCTGGCGCGCTGCACGGCG
ACGGCGGCCGGATCGCTGCGCTGGCGCATCCGCCTCGACACCGGCCTCGTGCCCGACATC
ACGATCGCCGTGCGCATGGACGAGGTGAACGAGGCGCCGCGCGACTACTATGTGCTGCCC
AGCATCGACATGACCGTCGGGAAACTGAAGCTCGCCGAGCAGAACGGGCTCGCGCTCGAT
GCGTACCGGTTCGACACGCTCGACTTCTTCTACGCGCTCGCCTCGCGGGCCAGGATCGCG
GAGGTGGCCTGA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
Not Available

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6536

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
54913.2

# Drug_Target_2_Name:
Histidine ammonia-lyase

# Drug_Target_2_Number_of_Residues:
523

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00221	PAL

# Drug_Target_2_Protein_Sequence:
>Histidine ammonia-lyase
MLAMSPPKPAVELDRHIDLDQAHAVASGGARIVLAPPARDRCRASEARLGAVIREARHVY
GLTTGFGPLANRLISGENVRTLQANLVHHLASGVGPVLDWTTARAMVLARLVSIAQGASG
ASEGTIARLIDLLNSELAPAVPSRGTVGASGDLTPLAHMVLCLQGRGDFLDRDGTRLDGA
EGLRRGRLQPLDLSHRDALALVNGTSAMTGIALVNAHACRHLGNWAVALTALLAECLRGR
TEAWAAALSDLRPHPGQKDAAARLRARVDGSARVVRHVIAERRLDAGDIGTEPEAGQDAY
SLRCAPQVLGAGFDTLAWHDRVLTIELNAVTDNPVFPPDGSVPALHGGNFMGQHVALTSD
ALATAVTVLAGLAERQIARLTDERLNRGLPPFLHRGPAGLNSGFMGAQVTATALLAEMRA
TGPASIHSISTNAANQDVVSLGTIAARLCREKIDRWAEILAILALCLAQAAELRCGSGLD
GVSPAGKKLVQALREQFPPLETDRPLGQEIAALATHLLQQSPV

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q3IWB0

# Drug_Target_2_SwissProt_Name:
Q3IWB0_RHOS4

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
7.66

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
MIF

# Drug_Target_3_GenBank_ID_Gene:
M25639

# Drug_Target_3_GenBank_ID_Protein:
188556

# Drug_Target_3_GeneCard_ID:
MIF

# Drug_Target_3_Gene_Name:
MIF

# Drug_Target_3_Gene_Sequence:
>348 bp
ATGCCGATGTTCATCGTAAACACCAACGTGCCCCGCGCCTCCGTGCCGGACGGGTTCCTC
TCCGAGCTCACCCAGCAGCTGGCGCAGGCCACCGGCAAGCCCCCCCAGTACATCGCGGTG
CACGTGGTCCCGGACCAGCTCATGGCCTTCGGCGGCTCCAGCGAGCCGTGCGCGCTCTGC
AGCCTGCACAGCATCGGCAAGATCGGCGGCGCGCAGAACCGCTCCTACAGCAAGCTGCTG
TGCGGCCTGCTGGCCGAGCGCCTGCGCATCAGCCCGGACAGGGTCTACATCAACTATTAC
GACATGAACGCGGCCAGTGTGGGCTGGAACAACTCCACCTTCGCCTAA

# Drug_Target_3_General_Function:
Involved in cytokine activity

# Drug_Target_3_General_References:
10353846	Lubetsky JB, Swope M, Dealwis C, Blake P, Lolis E: Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry. 1999 Jun 1;38(22):7346-54.
11089976	Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J: Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature. 2000 Nov 9;408(6809):211-6.
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
12681488	Shen L, Hu J, Lu H, Wu M, Qin W, Wan D, Li YY, Gu J: The apoptosis-associated protein BNIPL interacts with two cell proliferation-related proteins, MIF and GFER. FEBS Lett. 2003 Apr 10;540(1-3):86-90.
1286669	Hochstrasser DF, Frutiger S, Paquet N, Bairoch A, Ravier F, Pasquali C, Sanchez JC, Tissot JD, Bjellqvist B, Vargas R, et al.: Human liver protein map: a reference database established by microsequencing and gel comparison. Electrophoresis. 1992 Dec;13(12):992-1001.
2552447	Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark SC, David JR: Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7522-6.
7679497	Wistow GJ, Shaughnessy MP, Lee DC, Hodin J, Zelenka PS: A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1272-5.
7683862	Zeng FY, Weiser WY, Kratzin H, Stahl B, Karas M, Gabius HJ: The major binding protein of the interferon antagonist sarcolectin in human placenta is a macrophage migration inhibitory factor. Arch Biochem Biophys. 1993 May 15;303(1):74-80.
7947826	Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R: Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry. 1994 Nov 29;33(47):14144-55.
8188240	Paralkar V, Wistow G: Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics. 1994 Jan 1;19(1):48-51.
8234256	Mikayama T, Nakano T, Gomi H, Nakagawa Y, Liu YC, Sato M, Iwamatsu A, Ishii Y, Weiser WY, Ishizaka K: Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10056-60.
8610159	Kato Y, Muto T, Tomura T, Tsumura H, Watarai H, Mikayama T, Ishizaka K, Kuroki R: The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3007-10.
8643551	Sun HW, Bernhagen J, Bucala R, Lolis E: Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5191-6.
8766818	Sugimoto H, Suzuki M, Nakagawa A, Tanaka I, Nishihira J: Crystal structure of macrophage migration inhibitory factor from human lymphocyte at 2.1 A resolution. FEBS Lett. 1996 Jul 1;389(2):145-8.

# Drug_Target_3_HGNC_ID:
HGNC:7097

# Drug_Target_3_HPRD_ID:
01091

# Drug_Target_3_ID:
3384

# Drug_Target_3_Locus:
22q11.23

# Drug_Target_3_Molecular_Weight:
12476

# Drug_Target_3_Name:
Macrophage migration inhibitory factor

# Drug_Target_3_Number_of_Residues:
115

# Drug_Target_3_PDB_ID:
1GIF

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01187	MIF

# Drug_Target_3_Protein_Sequence:
>Macrophage migration inhibitory factor
MPMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALC
SLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA

# Drug_Target_3_Reaction:
keto-phenylpyruvate = enol-phenylpyruvate

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
The expression of MIF at sites of inflammation suggest a role for the mediator in regulating the function of macrophage in host defense. Also acts as a phenylpyruvate tautomerase

# Drug_Target_3_SwissProt_ID:
P14174

# Drug_Target_3_SwissProt_Name:
MIF_HUMAN

# Drug_Target_3_Synonyms:
EC 5.3.2.1
GIF
Glycosylation-inhibiting factor
MIF
Phenylpyruvate tautomerase

# Drug_Target_3_Theoretical_pI:
8.05

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB01880
